Perfusate adsorption during ex vivo lung perfusion improves early post-transplant lung function.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
02 2021
Historique:
received: 07 05 2019
revised: 29 11 2019
accepted: 05 12 2019
pubmed: 24 3 2020
medline: 18 2 2021
entrez: 24 3 2020
Statut: ppublish

Résumé

Improvement in ex vivo lung perfusion protocols could increase the number of donors available for transplantation and protect the lungs from primary graft dysfunction. We hypothesize that perfusate adsorption during ex vivo lung perfusion reconditions the allograft to ischemia-reperfusion injury after lung transplantation. Donor pig lungs were preserved for 24 hours at 4°C, followed by 6 hours of ex vivo lung perfusion according to the Toronto protocol. The perfusate was additionally adsorbed through a CytoSorb adsorber (CytoSorbents, Berlin, Germany) in the treatment group, whereas control lungs were perfused according to the standard protocol (n = 5, each). Ex vivo lung perfusion physiology and biochemistry were monitored. Upon completion of ex vivo lung perfusion, a left single lung transplantation was performed. Oxygenation function and lung mechanics were assessed during a 4-hour reperfusion period. The inflammatory response was determined during ex vivo lung perfusion and reperfusion. The cytokine concentrations in the perfusate were markedly lower with the adsorber, resulting in improved ex vivo lung perfusion physiology and biochemistry during the 6-hour perfusion period. Post-transplant dynamic lung compliance was markedly better during the 4-hour reperfusion period in the treatment group. Isolated allograft oxygenation function and dynamic compliance continued to be superior in the adsorber group at the end of reperfusion, accompanied by a markedly decreased local inflammatory response. Implementation of an additional cytokine adsorber has refined the standard ex vivo lung perfusion protocol. Furthermore, cytokine removal during ex vivo lung perfusion improved immediate post-transplant graft function together with a less intense inflammatory response to reperfusion in pigs. Further studies are warranted to understand the beneficial effects of perfusate adsorption during ex vivo lung perfusion in the clinical setting.

Identifiants

pubmed: 32201002
pii: S0022-5223(20)30472-4
doi: 10.1016/j.jtcvs.2019.12.128
pii:
doi:

Substances chimiques

Cytokines 0
Meropenem FV9J3JU8B1
Methylprednisolone X4W7ZR7023

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e109-e121

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Ilker Iskender (I)

Department of Thoracic Surgery, University Hospital Zurich-University of Zurich, Zurich, Switzerland.

Stephan Arni (S)

Department of Thoracic Surgery, University Hospital Zurich-University of Zurich, Zurich, Switzerland.

Tatsuo Maeyashiki (T)

Department of Thoracic Surgery, University Hospital Zurich-University of Zurich, Zurich, Switzerland.

Necati Citak (N)

Department of Thoracic Surgery, University Hospital Zurich-University of Zurich, Zurich, Switzerland.

Mareike Sauer (M)

Department of Surgical Research, University Hospital Zurich-University of Zurich, Zurich, Switzerland.

Josep Monné Rodriguez (JM)

Department of Veterinary Pathology, University of Zurich, Zurich, Switzerland.

Thomas Frauenfelder (T)

Institute of Diagnostic and Interventional Radiology, University Hospital Zurich-University of Zurich, Zurich, Switzerland.

Isabelle Opitz (I)

Department of Thoracic Surgery, University Hospital Zurich-University of Zurich, Zurich, Switzerland.

Walter Weder (W)

Department of Thoracic Surgery, University Hospital Zurich-University of Zurich, Zurich, Switzerland.

Ilhan Inci (I)

Department of Thoracic Surgery, University Hospital Zurich-University of Zurich, Zurich, Switzerland. Electronic address: ilhan.inci@usz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH